肿瘤消融市场：按技术、治疗方法、应用和地区划分

肿瘤消融市场预计在2026年达到17.557亿美元，预计到2033年将达到37.411亿美元。预计从2026年到2033年，其复合年增长率将达到11.5%。

这种新型癌症治疗方法的有效性取决于两个因素：肿瘤大小和探针的可及性。通常，对于直径小于3公分且易于经皮治疗的癌症，治疗重点在于彻底根除恶性肿瘤。随着癌症的生长，根除难度增加，因此早期治疗至关重要。

市场动态

老年人口的持续成长加重了医疗保健系统的经济负担。根据美国国家人口与社会科学研究所预测，美国65岁及以上人口将从2018年的5,200万增加到2060年的约9,500万，翻倍。老年人口的成长将推动肿瘤消融治疗设备市场需求的成长。

另一方面，对于在美国销售的医疗设备，美国食品药物管理局（FDA）下属的医疗设备和放射健康中心负责管理生产、标籤、包装和储存的框架和标准。为了获得批准或授权，每个组织都必须遵守该公共监管机构制定的详细标准清单，并保存相关的完整文件。

本报告的主要特点

• 本报告指出了各个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
• 此外，它还提供了有关市场驱动因素和限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
• 本报告根据以下参数分析了全球肿瘤消融市场主要企业的概况：公司概况、产品系列、主要亮点、财务表现和策略。
• 本节根据以下参数介绍全球肿瘤消融市场的主要企业：公司概况、产品系列、主要亮点、财务表现和策略。
• 本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、产品线更新、市场扩张和行销策略做出明智的决策。
• 《全球肿瘤消融市场》报告面向该行业的各种相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
• 相关人员可以透过分析全球肿瘤消融市场中使用的各种策略矩阵来促进决策。

目录

第一章：分析目标与假设

• 分析目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章：市场动态、监管与趋势分析

• 市场动态
  • 癌症发生率增加
  • 肿瘤消融治疗相关的併发症
  • 人们对使用传统治疗方法进行消融手术的认识不断提高
• 影响分析
• 主要亮点
• 法规环境
• 产品上市及核准
• PEST分析
• 波特五力分析
• 企业合併趋势

第四章 全球肿瘤消融市场：依技术划分（2026-2033 年）

• 射频消融术
• 微波消融术
• 冷冻消融术
• 不可逆电穿孔
• 雷射辅助热消融
• 其他消融技术

第五章 全球肿瘤消融市场：依治疗方法划分（2026-2033 年）

• 外科消融术
• 腹腔镜消融术
• 经皮术

第六章 全球肿瘤消融市场：依应用领域划分（2026-2033年）

• 肾癌
• 肝癌
• 乳癌
• 肺癌
• 摄护腺癌
• 结肠癌
• 其他癌症

第七章 全球肿瘤消融市场：按地区划分（2026-2033 年）

• 北美洲
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东和非洲

第八章 竞争情势

• Medtronic
• Boston Scientific Corporation
• Angio Dynamics
• Johnson&Johnson Services Inc.
• Theraclion
• EDAP TMS
• HS Hospital Service SPA
• IceCure Medical

第九章

• 分析方法
• 关于 Coherent Market Insights

Tumor Ablation Market is estimated to be valued at USD 1,755.7 Mn in 2026 and is expected to reach USD 3,741.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 11.5% from 2026 to 2033.

The efficiency of this new method in curing cancer based on two things the size of the tumor and its convenience to the probes. Generally, for cancers 3 cm or less and easily used percutaneously the focus is to totally kill the malignancy. The larger the cancer the more problematic it is to gain contest cancer fatality, hence early therapy is vital.

Market Dynamics

Continuous increase in geriatric population is rising the financial burden on the healthcare system. As per Population Reference Bureau, the count of people in the U.S. aged 65 and above is assessed to approximately double from 52 million in 2018 to 95 million by 2060. Such increase in elderly population will consequently lead in greater need for ablation devices for therapy of tumor, fueling the market

On contrary, for introduced tools sold in the U.S., FDA's Center for Devices and Radiological Health controls the framework and standards about production, labeling, packaging, and storage. To receive grants and permissions, the organizations require to comply with an exhaustive list of standards offered by official regulatory and keep complete documentation of the similar things.

Key features of the study

• This report provides in-depth analysis of the global tumor ablation market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global tumor ablation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Major players in the global tumor ablation therapy market are Medtronic, Johnson & Johnson Services Inc., Boston Scientific Corporation, IceCure Medical, EDAP TMS, Theraclion, H.S. Hospital Service SPA and AngioDyna mics.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global tumor ablation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tumor ablation market

Global Tumor Ablation Market Segmentation

• By Technology
  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryo Ablation
  • Irreversible Electroporation
  • Laser Based Thermal Ablation
  • Other Ablation Technologies
• By Treatment
  • Surgical Ablation
  • Laparoscopic Ablation
  • Percutaneous Ablation
• By Application
  • Kidney Cancers
  • Liver Cancers
  • Breast Cancers
  • Lung Cancers
  • Prostate Cancers
  • Colorectal Cancers
  • Other Cancers
• By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa
  • GCC Countries
  • Israel
  • Rest of Middle East & Africa
• Key Players
  • Medtronic
  • Johnson & Johnson Services Inc.
  • Boston Scientific Corporation
  • IceCure Medical
  • EDAP TMS
  • Theraclion
  • H.S. Hospital Service SPA
  • AngioDynamics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Technology
  • Market Snapshot, By Treatment
  • Market Snapshot, By Application
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Rising incidences of cancer
  • Complications linked to tumor ablation therapy
  • Rising perception regarding ablation process through conventional therapeutics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Tumor Ablation Market, By Technology, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033(%)
  • Y-o-Y Growth Analysis, 2026-2033
  • Segment Trends
• Radiofrequency Ablation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Microwave Ablation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Cryo Ablation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Irreversible Electroporation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Laser Based Thermal Ablation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Other Ablation Technologies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

5. Global Tumor Ablation Market, By Treatment, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033(%)
  • Y-o-Y Growth Analysis, 2026-2033
  • Segment Trends
• Surgical Ablation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Laparoscopic Ablation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Percutaneous Ablation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

6. Global Tumor Ablation Market, By Application, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026 and 2033(%)
  • Y-o-Y Growth Analysis, 2026-2033
  • Segment Trends
• Kidney Cancers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Liver Cancers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Breast Cancers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Lung Cancers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Prostate Cancers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Colorectal Cancers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)
• Other Cancers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Mn)

7. Global Tumor Ablation Market, By Region, 2026-2033, (USD Mn)

• Introduction
  • Market Share Analysis, 2026-2033(%)
  • Y-o-Y Growth Analysis, 2026-2033
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2026-2033, (USD Mn)
  • Market Size and Forecast and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2026-2033, (USD Mn)
  • Market Size and Forecast and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2026-2033, (USD Mn)
  • Market Size and Forecast and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2026-2033, (USD Mn)
  • Market Size and Forecast and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)
• Middle East &Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2026-2033, (USD Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2026-2033, (USD Mn)
  • Market Size and Forecast and Y-o-Y Growth, By Application, 2026-2033, (USD Mn)

8. Competitive Landscape

• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Angio Dynamics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Johnson& Johnson Services Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Theraclion
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• EDAP TMS
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• H.S Hospital Service SPA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• IceCure Medical
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

9. Section

• Research Methodology
• About Us